Compare Eni SpA (E) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eni SpA vs Viatris Inc — how do they compare? Eni SpA trades at $55.61 (market cap $80.32B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: Eni SpA is far larger — about 4.3× Viatris Inc's market cap, and Eni SpA pays the higher dividend (4.4%). Which is the better fit depends on your goals.
| E | VTRS | |
|---|---|---|
Market Cap | $80.32B | $18.69B |
Sector | Energy | Health |
52-Week High | $57.61 | $17.86 |
52-Week Low | $34.03 | $9.49 |
Enterprise Value | $105.61B | $30.80B |
Dividend Yield | 4.4% | 2.95% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
